Suppr超能文献

噬菌体疗法的动物模型。

Animal Models of Phage Therapy.

作者信息

Penziner Samuel, Schooley Robert T, Pride David T

机构信息

Department of Medicine, University of California, San Diego, San Diego, CA, United States.

Department of Pathology, University of California, San Diego, San Diego, CA, United States.

出版信息

Front Microbiol. 2021 Jan 28;12:631794. doi: 10.3389/fmicb.2021.631794. eCollection 2021.

Abstract

Amidst the rising tide of antibiotic resistance, phage therapy holds promise as an alternative to antibiotics. Most well-designed studies on phage therapy exist in animal models. In order to progress to human clinical trials, it is important to understand what these models have accomplished and determine how to improve upon them. Here we provide a review of the animal models of phage therapy in Western literature and outline what can be learned from them in order to bring phage therapy closer to becoming a feasible alternative to antibiotics in clinical practice.

摘要

在抗生素耐药性不断上升的浪潮中,噬菌体疗法有望成为抗生素的替代方案。大多数关于噬菌体疗法的精心设计的研究都存在于动物模型中。为了推进到人体临床试验,了解这些模型已经取得的成果并确定如何改进它们非常重要。在此,我们对西方文献中噬菌体疗法的动物模型进行综述,并概述可以从中学到什么,以便使噬菌体疗法更接近成为临床实践中抗生素的可行替代方案。

相似文献

1
Animal Models of Phage Therapy.
Front Microbiol. 2021 Jan 28;12:631794. doi: 10.3389/fmicb.2021.631794. eCollection 2021.
2
Biological challenges of phage therapy and proposed solutions: a literature review.
Expert Rev Anti Infect Ther. 2019 Dec;17(12):1011-1041. doi: 10.1080/14787210.2019.1694905. Epub 2019 Dec 2.
3
Phage Therapy in the Postantibiotic Era.
Clin Microbiol Rev. 2019 Jan 16;32(2). doi: 10.1128/CMR.00066-18. Print 2019 Apr.
4
Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
Curr Opin Microbiol. 2019 Oct;51:46-50. doi: 10.1016/j.mib.2019.03.005. Epub 2019 Jun 18.
5
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
Front Cell Infect Microbiol. 2018 Oct 23;8:376. doi: 10.3389/fcimb.2018.00376. eCollection 2018.
6
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Clin Ther. 2020 Sep;42(9):1659-1680. doi: 10.1016/j.clinthera.2020.07.014. Epub 2020 Aug 31.
8
Animal Models to Translate Phage Therapy to Human Medicine.
Int J Mol Sci. 2020 May 25;21(10):3715. doi: 10.3390/ijms21103715.
9
Bacteriophage-Delivering Hydrogels: Current Progress in Combating Antibiotic Resistant Bacterial Infection.
Antibiotics (Basel). 2021 Jan 29;10(2):130. doi: 10.3390/antibiotics10020130.
10
Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.
Biol Lett. 2019 Mar 29;15(3):20180895. doi: 10.1098/rsbl.2018.0895.

引用本文的文献

1
Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects.
Infect Med (Beijing). 2025 Feb 5;4(1):100168. doi: 10.1016/j.imj.2025.100168. eCollection 2025 Mar.
2
Recent insights on phage therapy against multidrug-resistant Acinetobacter baumannii.
AMB Express. 2025 Mar 12;15(1):44. doi: 10.1186/s13568-025-01837-1.
3
The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae.
Virol J. 2024 Aug 19;21(1):191. doi: 10.1186/s12985-024-02450-7.
4
Identification of Lytic Phages Against Multidrug-Resistant : Illuminating Hope on Antimicrobial-Resistance.
Phage (New Rochelle). 2024 Jun 21;5(2):91-98. doi: 10.1089/phage.2023.0038. eCollection 2024 Jun.
6
Rapid assessment of changes in phage bioactivity using dynamic light scattering.
PNAS Nexus. 2023 Nov 27;2(12):pgad406. doi: 10.1093/pnasnexus/pgad406. eCollection 2023 Dec.
7
Phage activity against Staphylococcus aureus is impaired in plasma and synovial fluid.
Sci Rep. 2023 Oct 24;13(1):18204. doi: 10.1038/s41598-023-45405-8.
8
Effective reduction of Enteritidis in broiler chickens using the UPWr_S134 phage cocktail.
Front Microbiol. 2023 Apr 27;14:1136261. doi: 10.3389/fmicb.2023.1136261. eCollection 2023.
9
Recent Progress in Phage Therapy to Modulate Multidrug-Resistant , including in Human and Poultry.
Antibiotics (Basel). 2022 Oct 13;11(10):1406. doi: 10.3390/antibiotics11101406.

本文引用的文献

1
Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance.
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11207-11216. doi: 10.1073/pnas.1919888117. Epub 2020 May 18.
2
Safety of bacteriophage therapy in severe Staphylococcus aureus infection.
Nat Microbiol. 2020 Mar;5(3):465-472. doi: 10.1038/s41564-019-0634-z. Epub 2020 Feb 17.
3
Phage Therapy as an Approach to Control Salmonella enterica serotype Enteritidis Infection in Mice.
Rev Soc Bras Med Trop. 2019 Nov 14;52:e20190290. doi: 10.1590/0037-8682-0290-2019. eCollection 2019.
4
Antibiotic development - economic, regulatory and societal challenges.
Nat Rev Microbiol. 2020 May;18(5):267-274. doi: 10.1038/s41579-019-0293-3. Epub 2019 Nov 19.
5
Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model.
J Glob Antimicrob Resist. 2020 Jun;21:34-41. doi: 10.1016/j.jgar.2019.09.018. Epub 2019 Oct 8.
6
An experimental mouse model for phage therapy of bacterial pathogens causing bacteremia.
Microb Pathog. 2019 Dec;137:103770. doi: 10.1016/j.micpath.2019.103770. Epub 2019 Oct 3.
7
The Virome of Cerebrospinal Fluid: Viruses Where We Once Thought There Were None.
Front Microbiol. 2019 Sep 6;10:2061. doi: 10.3389/fmicb.2019.02061. eCollection 2019.
8
Identification of Novel Bacteriophages with Therapeutic Potential That Target .
Infect Immun. 2019 Oct 18;87(11). doi: 10.1128/IAI.00512-19. Print 2019 Nov.
9
Bacteriophages Improve Outcomes in Experimental Ventilator-associated Pneumonia.
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1126-1133. doi: 10.1164/rccm.201812-2372OC.
10
Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus.
JAMA Otolaryngol Head Neck Surg. 2019 Aug 1;145(8):723-729. doi: 10.1001/jamaoto.2019.1191.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验